Calcium channel blockers (CCBs) show unproven efficacy for ischemic heart disease prophylaxis. Long-acting CCBs are recommended for hypertension, pending further safety trials.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: